Summary of PET/CT responses and relapses
Summary of responses . | All patients . | CDB received, mg/kg . | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intended CDB of 14.4 mg/kg . | Moderately reduced CDB of 10.5-14.1 mg/kg . | Severely reduced CDB of 2.4-9.6 mg/kg . | |||||||||||
N = 179 . | % . | Event(s) . | n = 81 . | % . | Event(s) . | n = 48 . | % . | Event(s) . | n = 50 . | % . | Event(s) . | ||
Interim PET/CT Deauville score | 1-3 | 130 | 73 | 10 | 62 | 77 | 8 | 33 | 69 | 1 | 35 | 70 | 1 |
4 | 30 | 17 | 8 | 15 | 19 | 6 | 7 | 15 | 2 | 8 | 16 | 0 | |
5 | 11 | 6 | 3 | 2 | 2 | 1 | 5 | 10 | 0 | 4 | 8 | 2 | |
NA | 8 | 4 | 1 | 2 | 2 | 0 | 3 | 6 | 0 | 3 | 6 | 1 | |
End-of-treatment PET/CT Deauville score | 1-3 | 135 | 75 | 6 | 63 | 78 | 5 | 30 | 63 | 0 | 42 | 84 | 1 |
4 | 8 | 4 | 2 | 3 | 4 | 2 | 4 | 8 | 0 | 1 | 2 | 0 | |
5 | 19 | 11 | 11 | 10 | 12 | 7 | 5 | 10 | 2 | 4 | 8 | 2 | |
NA | 17 | 9 | 3 | 5 | 6 | 1 | 9 | 19 | 1 | 3 | 6 | 1 |
Summary of responses . | All patients . | CDB received, mg/kg . | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intended CDB of 14.4 mg/kg . | Moderately reduced CDB of 10.5-14.1 mg/kg . | Severely reduced CDB of 2.4-9.6 mg/kg . | |||||||||||
N = 179 . | % . | Event(s) . | n = 81 . | % . | Event(s) . | n = 48 . | % . | Event(s) . | n = 50 . | % . | Event(s) . | ||
Interim PET/CT Deauville score | 1-3 | 130 | 73 | 10 | 62 | 77 | 8 | 33 | 69 | 1 | 35 | 70 | 1 |
4 | 30 | 17 | 8 | 15 | 19 | 6 | 7 | 15 | 2 | 8 | 16 | 0 | |
5 | 11 | 6 | 3 | 2 | 2 | 1 | 5 | 10 | 0 | 4 | 8 | 2 | |
NA | 8 | 4 | 1 | 2 | 2 | 0 | 3 | 6 | 0 | 3 | 6 | 1 | |
End-of-treatment PET/CT Deauville score | 1-3 | 135 | 75 | 6 | 63 | 78 | 5 | 30 | 63 | 0 | 42 | 84 | 1 |
4 | 8 | 4 | 2 | 3 | 4 | 2 | 4 | 8 | 0 | 1 | 2 | 0 | |
5 | 19 | 11 | 11 | 10 | 12 | 7 | 5 | 10 | 2 | 4 | 8 | 2 | |
NA | 17 | 9 | 3 | 5 | 6 | 1 | 9 | 19 | 1 | 3 | 6 | 1 |
Event: relapse during follow-up.
NA, not available.